CHAI Forms New Group to Address Artificial Intelligence Cyber Threats
The work group will develop playbooks and risk assessment tools to help healthcare organizations defend against advanced model risks.
The work group will develop playbooks and risk assessment tools to help healthcare organizations defend against advanced model risks.
Guidance addresses common challenges—from interoperability to network stability—to help healthcare organizations improve safety and efficiency in connected device operations.
AAMI has released TIR17:2024, updating guidance on ethylene oxide and new alternatives like chlorine dioxide and vaporized hydrogen peroxide.
The work group will develop playbooks and risk assessment tools to help healthcare organizations defend against advanced model risks.
“Bioburden reduction systems can play an important role in the ongoing efforts to help address shortages of FFRs,” says FDA’s Binita Ashar, MD.
Read MoreThe guidance aims to mitigate equipment shortages by requiring manufacturers to communicate any interruptions in their supply chains that could affect hospitals’ ability to treat patients with COVID-19.
Read More